News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,484 Results
Type
Article (45646)
Company Profile (497)
Press Release (671341)
Section
Business (211417)
Career Advice (2138)
Deals (37315)
Drug Delivery (97)
Drug Development (83932)
Employer Resources (172)
FDA (16610)
Job Trends (15390)
News (358194)
Policy (33931)
Tag
Academia (2711)
Alliances (51725)
Alzheimer's disease (1299)
Approvals (16529)
Artificial intelligence (157)
Bankruptcy (373)
Best Places to Work (11887)
Biotechnology (369)
Breast cancer (146)
Cancer (1205)
Cardiovascular disease (111)
Career advice (1789)
Cell therapy (260)
Clinical research (66533)
Collaboration (447)
Compensation (226)
COVID-19 (2650)
C-suite (108)
Data (1210)
Diabetes (163)
Diagnostics (6408)
Earnings (86677)
Employer resources (151)
Events (114396)
Executive appointments (350)
FDA (17209)
Funding (402)
Gene therapy (202)
GLP-1 (637)
Government (4522)
Healthcare (19316)
Infectious disease (2739)
Inflammatory bowel disease (117)
Interviews (335)
IPO (16725)
Job creations (3905)
Job search strategy (1523)
Layoffs (455)
Legal (8230)
Lung cancer (182)
Manufacturing (191)
Medical device (13556)
Medtech (13561)
Mergers & acquisitions (20678)
Metabolic disorders (446)
Neuroscience (1615)
NextGen Class of 2024 (6876)
Non-profit (4644)
Northern California (1579)
Obesity (256)
Opinion (210)
Patents (114)
People (58547)
Phase I (20842)
Phase II (29325)
Phase III (21738)
Pipeline (482)
Postmarket research (2646)
Preclinical (9018)
Radiopharmaceuticals (253)
Rare diseases (254)
Real estate (6259)
Regulatory (22574)
Research institute (2474)
Resumes & cover letters (367)
Southern California (1381)
Startups (3821)
United States (14664)
Vaccines (582)
Weight loss (191)
Date
Today (210)
Last 7 days (480)
Last 30 days (3569)
Last 365 days (37098)
2024 (35056)
2023 (41342)
2022 (52615)
2021 (57173)
2020 (55596)
2019 (48265)
2018 (36378)
2017 (33729)
2016 (33233)
2015 (39218)
2014 (33105)
2013 (28171)
2012 (30174)
2011 (30790)
2010 (28971)
Location
Africa (781)
Arizona (204)
Asia (40111)
Australia (6649)
California (3618)
Canada (1361)
China (280)
Colorado (159)
Connecticut (170)
Europe (87712)
Florida (493)
Georgia (126)
Illinois (373)
Indiana (212)
Kansas (99)
Maryland (620)
Massachusetts (2900)
Michigan (166)
Minnesota (290)
New Jersey (1040)
New York (1032)
North Carolina (791)
Northern California (1579)
Ohio (147)
Pennsylvania (888)
South America (1170)
Southern California (1381)
Texas (522)
Utah (96)
Washington State (393)
717,484 Results for "barrier therapeutics inc acquired by stiefel laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Crescita to Acquire Strategic Assets of Occy Laboratory
Crescita Therapeutics Inc. today announced that it has agreed to acquire all of the non-real estate business assets of Occy Laboratory Inc., (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).
June 20, 2024
·
5 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Press Releases
FzioMed, Inc. to Highlight its Adhesion Barrier Product Solutions at the European Society for Gynecological Endoscopy (ESGE) Congress
October 16, 2024
·
3 min read
Press Releases
Adnexus Biotechnologies Inc. Announces a Merger Agreement to Acquire Sanctum Therapeutics Corporation
November 6, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Proteologix, Inc. to be Acquired by Johnson & Johnson
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson
May 16, 2024
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics
October 30, 2024
·
4 min read
Press Releases
Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
November 26, 2024
·
13 min read
Deals
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
Crescita Therapeutics Inc. today announced that it has concluded the asset purchase agreement (the “Purchase Agreement”) to acquire all of the non-real estate business assets of Occy Laboratory Inc. (“Occy”), a Laval-based manufacturer and distributor of high-quality dermocosmetic products (the “Transaction”).
June 26, 2024
·
4 min read
1 of 71,749
Next
